Latest Share Purchase Plans News

CONNEQT Health has raised A$5.5 million through a two-tranche placement at a 15.4% discount, backed by key shareholders, to accelerate its commercial expansion and product development.

Acrow Limited has secured $70 million through a fully underwritten two-tranche placement to acquire Ausgroup Industrial Services and Preston SuperDeck, boosting its FY27 revenue and EBITDA guidance significantly.

Vitrafy Life Sciences has launched a non-underwritten Share Purchase Plan to raise approximately A$2 million, offering existing Australian and New Zealand shareholders the chance to buy shares at A$2.60 each, matching the recent institutional placement price.

Acrow Limited (ASX:ACF) is set to expand its Industrial Access and Construction Services footprint with a $54.5 million acquisition of Ausgroup and Preston SuperDeck, funded by a fully underwritten $70 million equity raise and a $10 million share purchase plan. The company also upgraded its FY27 revenue and EBITDA guidance by 21% and 15% respectively.

Strategic Elements Ltd has closed its Share Purchase Plan (SPP) after applications topped $3 million, exceeding the $2.5 million cap. The oversubscription highlights strong shareholder support as the company prepares for a more active phase leveraging the Pooled Development Fund structure.

Novonix has secured A$20.7 million from an institutional placement at a 33% discount, alongside a A$3 million Share Purchase Plan for existing shareholders, aiming to fund production capacity expansion amid growing battery demand.

ALS Limited has confirmed its ordinary dividend of AUD 0.231 per share for the six months ending March 2026, introducing multi-currency payment options and appointing Macquarie Securities to manage on-market share purchases for its Dividend Reinvestment Plan.

Sunshine Metals has kicked off a comprehensive airborne magnetic and radiometric survey at its Sybil Gold Project in Queensland, setting the stage for a drilling program targeting multiple high-grade prospects including the first-ever tests at Francis Creek East.

Southern Cross Electrical Engineering (ASX:SXE) has secured $150 million through a fully underwritten institutional placement priced at $4.00 per share, aiming to support new contracts and potential acquisitions. A $15 million share purchase plan will follow, offering existing shareholders a chance to participate.

Microba Life Sciences secures $5 million in a placement led by Sonic Healthcare to fund its push towards cashflow break-even by 2027, backed by strong diagnostic sales and AI-driven efficiencies.

Electro Optic Systems (ASX:EOS) has dramatically expanded its Share Purchase Plan from $25 million to $40 million after receiving $95 million in applications, reflecting robust support from retail investors. Approximately 5 million new shares will be issued at $8.00 each, matching recent institutional pricing.

Vitrafy Life Sciences has secured A$30 million through an institutional placement to ramp up manufacturing of its Guardion cryopreservation devices and expand US sales operations, with an additional A$2 million sought via a shareholder plan.